Interrelationships between energy metabolism and thyroid hormone metabolism during starvation in the rat

1980 ◽  
Vol 93 (3) ◽  
pp. 322-331 ◽  
Author(s):  
A. G. Burger ◽  
M. Berger ◽  
K. Wimpfheimer ◽  
E. Danforth

Abstract. Thyroid hormone metabolism and plasma concentrations of TSH were studied after short-term hypocaloric refeeding of rats starved for 2–6 days. Carbohydrate and protein (10 kcal) refeeding after 4 days of starvation resulted in a rapid increase in serum T3 (P<0.01) and, less consistently of T4. Plasma TSH did not change. These findings were not due to changes in the metabolic clearance rates or in thyroid hormone binding proteins, as the disappearance of injected labelled T3 and T4, and the free fractions of T3 and T4, were unchanged. Increased thyroidal secretion, and for T3, increased peripheral conversion from T4 were therefore responsible for these changes. Fat refeeding had no immediate effect on plasma T4, T3 or TSH. After 6 days of starvation, refeeding of any nutrient was ineffective in altering the plasma concentrations of T3 and T4. The intraperitoneal administration of nicotinamide (100 mg/100 g body weight) to starving animals caused an increase in blood glucose and a decrease in blood betahydroxybutyrate similar to that which followed carbohydrate refeeding; T3, however, did not increase. In spite of producing a profile of substrates in the serum similar to that found following carbohydrate refeeding, nicotinamide administration had no effect on the blood lactate/ pyruvate ratio which was increased following carbohydrate refeeding. Therefore, the cytoplasmic redox state, as reflected by the lactate/pyruvate ratio, may be closely related to the control of peripheral thyroid hormone metabolism.

1987 ◽  
Vol 112 (1) ◽  
pp. 171-175 ◽  
Author(s):  
C. Liniger ◽  
D. Pometta ◽  
A. G. Burger

ABSTRACT SR-202 is a non-iodinated potential lipid-altering agent. When administered (100 mg) three times per day for 3 days to six euthyroid subjects it was associated with a 30 ± 3% (mean ± s.e.m.) fall in 3,3′,5-tri-iodothyronine(T3)(P < 0·001), a reciprocal 104 ± 14% rise in 3,3′,5′-tri-iodothyronine (reverse T3, rT3) (P < 0·01), and a 37 ± 7% rise in thyroxine (T4) (P < 0·001). Basal and TRH-stimulated TSH did not change. These results suggested that SR-202 was acting as an inhibitor of the peripheral monodeiodination of T4 to T3. During a second study the same subjects received the same dose of SR-202 for a further 3 days following 15 days of progressive substitutive treatment with l-T4, which they continued to take at 200 μg/day until the end of the study. Despite higher levels of thyroid hormones in the substituted subjects, similar results were observed, serum T3 falling by 40 ± 2% (P < 0·001), serum rT3 and T4 rising by 168 ± 24% (P < 0·01) and 37 ± 9% (P < 0·01) respectively. These changes provide compelling evidence that SR-202 is an inhibitor of the peripheral conversion of T4 to T3 that acts on thyroid hormone metabolism without provoking a counter-regulatory pituitary response. It might prove to be a useful tool for the clinical investigation of thyroid function. J. Endocr. (1987) 112, 171–175


1993 ◽  
Vol 38 (4) ◽  
pp. 419-434 ◽  
Author(s):  
G. A. H. Heussen ◽  
G. J. Schefferlie ◽  
M. J. G. Talsma ◽  
H. van Til ◽  
M. J. W. Dohmen ◽  
...  

2005 ◽  
Vol 37 (11) ◽  
pp. 1247-1252 ◽  
Author(s):  
Alexandra M Dumitrescu ◽  
Xiao-Hui Liao ◽  
Mohamed S Y Abdullah ◽  
Joaquin Lado-Abeal ◽  
Fathia Abdul Majed ◽  
...  

1994 ◽  
Vol 79 (5) ◽  
pp. 1342-1346 ◽  
Author(s):  
J M Stouthard ◽  
T van der Poll ◽  
E Endert ◽  
P J Bakker ◽  
C H Veenhof ◽  
...  

1986 ◽  
pp. 449-454
Author(s):  
Katsumi Yoshida ◽  
Michiko Suzuki ◽  
Toshiro Sakurada ◽  
Hiroshi Fukazawa ◽  
Shintaro Saito ◽  
...  

1982 ◽  
Vol 16 (3) ◽  
pp. 303-313 ◽  
Author(s):  
PAX H. B. WILLEMSE ◽  
DIRK TH. SLEIJFER ◽  
WIM J. SLUITER ◽  
HEIMEN SCHRAFFORDT KOOPS ◽  
HIERONYMUS DOORENBOS

Sign in / Sign up

Export Citation Format

Share Document